A Study of Bevacizumab, Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (A-FOLFOXIRI) Compared With Bevacizumab, Infusional Fluorouracil, Leucovorin, and Irinotecan/Oxaliplatin (A-FOLFIRI/FOLFOX) as First-line Treatment for Metastatic Right-sided Colon Cancer

Clinical trial NCT03641976 · UNKNOWN

Trial details

NCT number: NCT03641976
Sponsor: Yonsei University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Unresectable Metastatic Right-sided Colon Cancer Starting First-line Combination Chemotherapy Unresectable Metastatic Right-sided Colon Cancer, Stage IV

Start date: 2019-01-03
Primary completion: 2024-06-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.